Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

HB736: Health insurance; required provisions regarding prior authorization for prescription drugs.

signed by governor

<b>Health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.</b> Amends existing required provisions for health carrier contracts related to prior authorizations for prescription drugs. Current law requires that if prior authorization is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, health carriers may not revoke, limit, condition, modify, or restrict that authorization except in certain circumstances. The bill requires this limitation on carriers to apply for the duration of the authorization, which the bill requires to be a minimum of six months for initial authorizations and a minimum of 12 months for continued authorizations. The bill adds circumstances under which a prior authorization may be revoked, limited, conditioned, modified, or restricted by a carrier, including (i) a final action by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer communicating a patient efficacy issue that would affect the authorization and (ii) when additional safety and efficacy monitoring is clinically appropriate or recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer.

Official bill page · Source: Richmond Sunlight

Ask about HB736

Full bill text

Version CHAP0213 · 2026-04-06

Full text

Changes in this version: added text deleted text

An Act to amend and reenact § 38.2-3407.15:2, as it shall become effective, of the Code of Virginia, relating to health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.

Be it enacted by the General Assembly of Virginia:

1. That § 38.2-3407.15:2, as it shall become effective, of the Code of Virginia is amended and reenacted as follows:

§ 38.2-3407.15:2. (Effective January 1, 2027) Carrier contracts; required provisions regarding prior authorization for drug benefits.

A. As used in this section, unless the context requires a different meaning:

"Carrier" has the same meaning as provided in subsection A of § 38.2-3407.15.

"Prior authorization" means the approval process used by a carrier before certain drug benefits may be provided.

"Provider contract" has the same meaning as provided in subsection A of § 38.2-3407.15.

"Supplementation" means a request communicated by the carrier to the prescriber or his designee for additional information, limited to items specifically requested on the applicable prior authorization request, necessary to approve or deny such request.

B. Any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, shall contain specific provisions that:

1. Require the carrier to, in a method of its choosing, accept telephonic, facsimile, or electronic submission of prior authorization requests that are delivered from e-prescribing systems, electronic health record systems, and health information exchange platforms that utilize the National Council for Prescription Drug Programs' SCRIPT standards;

2. Require that the carrier communicate to the prescriber or his designee within 24 hours, including weekend hours, of submission of an urgent prior authorization request to the carrier, if submitted telephonically or in an alternate method directed by the carrier, that the request is approved, denied, or requires supplementation;

3. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a fully completed prior authorization request, that the request is approved, denied, or requires supplementation;

4. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a properly completed supplementation from the prescriber or his designee, that the request is approved or denied;

5. Require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not, for the duration of the authorization, which shall be no less than six months for initial authorizations and 12 months for continued authorizations, revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety or efficacy issue that would affect the authorization alone or in combination with other authorizations; (iii) additional safety and efficacy monitoring is clinically appropriate or recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer; (iv) a combination of drugs prescribed would cause a drug interaction; or (iv) (v) a generic or biosimilar is added to the prescription drug formulary. Nothing in this section shall require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered;

6. Require that if the prior authorization request is denied, the carrier shall communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within the timeframes established by subdivision 3 or 4, as applicable, the reasons for the denial;

7. Require that prior authorization approved by another carrier be honored, upon the carrier's receipt from the prescriber or his designee of a record demonstrating the previous carrier's prior authorization approval or any written or electronic evidence of the previous carrier's coverage of such drug, at least for the initial 90 days of a member's prescription drug benefit coverage under a new health plan, subject to the provisions of the new carrier's evidence of coverage and any exception listed in subdivision 5;

8. Require that a tracking system be used by the carrier for all prior authorization requests and that the identification information be provided electronically, telephonically, or by facsimile to the prescriber or his designee, upon the carrier's response to the prior authorization request;

9. Require that the carrier's prescription drug formularies, all drug benefits subject to prior authorization by the carrier, all of the carrier's prior authorization procedures, and all prior authorization request forms accepted by the carrier be made available through one central location on the carrier's website and that such information be updated by the carrier within seven days of approved changes;

10. Require a carrier to honor a prior authorization issued by the carrier for a drug, other than an opioid, regardless of changes in dosages of such drug, provided such drug is prescribed consistent with U.S. Food and Drug Administration-labeled dosages;

11. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the covered person changes plans with the same carrier and the drug is a covered benefit with the current health plan;

12. Require a carrier, when requiring a prescriber to provide supplemental information that is in the covered individual's health record or electronic health record, to identify the specific information required;

13. Require that no prior authorization be required for at least one drug prescribed for substance abuse medication-assisted treatment, provided that (i) the drug is a covered benefit, (ii) the prescription does not exceed the FDA-labeled dosages, and (iii) the drug is prescribed consistent with the regulations of the Board of Medicine;

14. Require that when any carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization shall be required by the carrier, provided that (i) the drug is a covered benefit; (ii) the prescription does not exceed the FDA-labeled dosages; (iii) the prescription has been continuously issued for no fewer than three months; and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. Nothing in this subdivision shall prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription for the drug is issued;

15. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued, provided that the drug and prescription are consistent with the applicable provisions of subdivision 14;

16. Require a carrier, beginning July 1, 2025, notwithstanding the provisions of subdivision 1 or any other provision of this section, to establish and maintain an online process that (i) links directly to all e-prescribing systems and electronic health record systems that utilize the National Council for Prescription Drug Programs SCRIPT standard and the National Council for Prescription Drug Programs Real Time Benefit Standard; (ii) can accept electronic prior authorization requests from a provider; (iii) can approve electronic prior authorization requests (a) for which no additional information is needed by the carrier to process the prior authorization request, (b) for which no clinical review is required, and (c) that meet the carrier's criteria for approval; (iv) links directly to real-time patient out-of-pocket costs for the prescription drug, considering copayment and deductible; and (v) otherwise meets the requirements of this section. No carrier shall (a) impose a fee or charge on any person for accessing the online process as required by this subdivision or (b) access, absent provider consent, provider data via the online process other than for the enrollee. No later than July 1, 2024, a carrier shall provide contact information of any third-party vendor or other entity the carrier will use to meet the requirements of this subdivision or the requirements of § 38.2-3407.15:7 to any provider that requests such information. A carrier that posts such contact information on its website shall be considered to have met this requirement; and

17. Require a participating health care provider, beginning July 1, 2025, to ensure that any e-prescribing system or electronic health record system owned by or contracted for the provider to maintain an enrollee's health record has the ability to access, at the point of prescribing, the electronic prior authorization process established by a carrier as required by subdivision 16 and the real-time patient-specific benefit information, including out-of-pocket costs and more affordable medication alternatives made available by a carrier pursuant to § 38.2-3407.15:7. A provider may request a waiver of compliance under this subdivision for undue hardship for a period specified by the appropriate regulatory authority with the Health and Human Resources Secretariat.

C. The Commission shall have no jurisdiction to adjudicate individual controversies arising out of this section.

D. This section shall apply with respect to any contract between a carrier and a participating health care provider or its contracting agent that is entered into, amended, extended, or renewed on or after January 1, 2016.

E. Notwithstanding any law to the contrary, the provisions of this section shall not apply to:

1. Coverages issued pursuant to Title XVIII of the Social Security Act, 42 U.S.C. § 1395 et seq. (Medicare), Title XIX of the Social Security Act, 42 U.S.C. § 1396 et seq. (Medicaid), Title XXI of the Social Security Act, 42 U.S.C. § 1397aa et seq. (CHIP), 5 U.S.C. § 8901 et seq. (federal employees), or 10 U.S.C. § 1071 et seq. (TRICARE);

2. Accident only, credit or disability insurance, long-term care insurance, TRICARE supplement, Medicare supplement, or workers' compensation coverages;

3. Any dental services plan or optometric services plan as defined in § 38.2-4501; or

4. Any health maintenance organization that (i) contracts with one multispecialty group of physicians who are employed by and are shareholders of the multispecialty group, which multispecialty group of physicians may also contract with health care providers in the community; (ii) provides and arranges for the provision of physician services by such multispecialty group physicians or by such contracted health care providers in the community; and (iii) receives and processes at least 85 percent of prescription drug prior authorization requests in a manner that is interoperable with e-prescribing systems, electronic health records, and health information exchange platforms.

2. That the provisions of this act shall apply to contracts entered into, amended, or renewed on or after January 1, 2027.

Legislative actions

2026-03-12 · history

Signed by President

2026-03-09 · history

Enrolled

2026-03-04 · history

Passed by for the day Block Vote (Voice Vote)

2026-02-16 · history

Engrossed by House as amended

2026-04-06 · history

Approved by Governor-Chapter 213 (effective 7/1/2026)

2026-03-05 · history

Read third time

2026-03-12 · history

Bill text as passed House and Senate (HB736ER)

2026-01-13 · history

Prefiled and ordered printed; Offered 01-14-2026 26105188D

2026-02-17 · history

Fiscal Impact Statement from Department of Planning and Budget (HB736)

2026-03-12 · history

Fiscal Impact Statement from Department of Planning and Budget (HB736)

2026-03-09 · history

Bill text as passed House and Senate (HB736ER)

2026-02-16 · history

Read second time

2026-02-13 · history

Subcommittee recommends reporting

2026-02-03 · history

Subcommittee recommends reporting with amendment(s) and referring to Appropriations

2026-02-13 · history

Reported from Appropriations

2026-02-17 · history

Read third time and passed House Block Vote (97-Y 0-N 0-A)

2026-02-15 · history

Read first time

2026-03-05 · history

Passed Senate Block Vote (39-Y 0-N 0-A)

2026-02-18 · history

Referred to Committee on Commerce and Labor

2026-01-13 · history

Referred to Committee on Labor and Commerce

2026-02-13 · history

Reported from Appropriations (22-Y 0-N)

2026-03-04 · history

Constitutional reading dispensed Block Vote (on 2nd reading) (39-Y 0-N 0-A)

2026-02-03 · history

Subcommittee recommends reporting with amendment(s) and referring to Appropriations (9-Y 0-N)

2026-03-04 · history

Rules suspended

2026-02-13 · history

Subcommittee recommends reporting (7-Y 0-N)

2026-01-20 · history

Assigned HCL sub: Subcommittee #1

2026-02-18 · history

Constitutional reading dispensed (on 1st reading)

2026-02-05 · history

Reported from Labor and Commerce with amendment(s) and referred to Appropriations (22-Y 0-N)

2026-03-04 · history

Passed by for the day

2026-04-06 · history

Acts of Assembly Chapter text (CHAP0213)

2026-02-05 · history

Reported from Labor and Commerce with amendment(s) and referred to Appropriations

2026-02-05 · history

Assigned HAPP sub: Compensation and Retirement

2026-02-16 · history

committee amendments agreed to

2026-03-14 · history

Enrolled Bill communicated to Governor on March 14, 2026

2026-03-12 · history

Enrolled

2026-03-12 · history

Signed by Speaker

2026-03-02 · history

Reported from Commerce and Labor

2026-03-02 · history

Reported from Commerce and Labor (13-Y 0-N)

2026-03-14 · history

Governor's Action Deadline 11:59 p.m., April 13, 2026

Raw source record
{
    "id": 84573,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb736\/",
    "tags": {
        "151035": "health insurance",
        "151036": "prescription drugs",
        "151037": "regulation",
        "151038": "medicine"
    },
    "text": [
        {
            "date": "2026-01-13",
            "number": "HB736",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb736.pdf"
        },
        {
            "date": "2026-02-16",
            "number": "HB736E"
        },
        {
            "date": "2026-03-09",
            "number": "HB736ER"
        },
        {
            "date": "2026-04-06",
            "number": "CHAP0213"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "hb736",
    "patron": "Maldonado, Michelle",
    "status": "signed by governor",
    "chamber": "house",
    "changes": null,
    "outcome": "passed",
    "related": [
        {
            "id": 84310,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb481",
            "status": "signed by governor",
            "catch_line": "Prior authorization; requiring physician review for denial.",
            "date_introduced": "January 12, 2026"
        },
        {
            "id": 84462,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb625",
            "status": "signed by governor",
            "catch_line": "Health insurance; limit on cost-sharing payments for prescription drugs under certain plans.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 85877,
            "name": "Appropriations",
            "year": 2026,
            "count": 3,
            "number": "hb1390",
            "status": "failed subcommittee",
            "catch_line": "Health insurance; pharmacies, freedom of choice, delivery of prescription drugs, penalties.",
            "date_introduced": "January 21, 2026"
        },
        {
            "id": 84051,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "sb161",
            "status": "signed by governor",
            "catch_line": "Health insurance; limit on cost-sharing payments for prescription drugs under certain plans.",
            "date_introduced": "January 07, 2026"
        },
        {
            "id": 85117,
            "name": "Commerce and Labor",
            "year": 2026,
            "count": 3,
            "number": "hb1214",
            "status": "signed by governor",
            "catch_line": "Health insurance; cost-sharing payments for insulin and diabetes equipment and supplies, limit.",
            "date_introduced": "January 14, 2026"
        }
    ],
    "summary": "<b>Health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.<\/b> Amends existing required provisions for health carrier contracts related to prior authorizations for prescription drugs. Current law requires that if prior authorization is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, health carriers may not revoke, limit, condition, modify, or restrict that authorization except in certain circumstances. The bill requires this limitation on carriers to apply for the duration of the authorization, which the bill requires to be a minimum of six months for initial authorizations and a minimum of 12 months for continued authorizations. The bill adds circumstances under which a prior authorization may be revoked, limited, conditioned, modified, or restricted by a carrier, including (i) a final action by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer communicating a patient efficacy issue that would affect the authorization and (ii) when additional safety and efficacy monitoring is clinically appropriate or recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer.",
    "version": "CHAP0213",
    "copatron": [
        {
            "shortname": "ajlaufer",
            "partisanship": 23,
            "name_formatted": "Del. Amy Laufer (D-Albemarle)"
        }
    ],
    "committee": "Appropriations",
    "full_text": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:2\/'>38.2-3407.15:2<\/a>, as it shall become effective, of the Code of Virginia, relating to health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:2\/'>38.2-3407.15:2<\/a>, as it shall become effective, of the Code of Virginia is amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:2\/'>38.2-3407.15:2<\/a>. (Effective January 1, 2027) Carrier contracts; required provisions regarding prior authorization for drug benefits.<\/p><p class=\"section\">A. As used in this section, unless the context requires a different meaning:<\/p><p class=\"section\">\"Carrier\" has the same meaning as provided in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">\"Prior authorization\" means the approval process used by a carrier before certain drug benefits may be provided.<\/p><p class=\"section\">\"Provider contract\" has the same meaning as provided in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">\"Supplementation\" means a request communicated by the carrier to the prescriber or his designee for additional information, limited to items specifically requested on the applicable prior authorization request, necessary to approve or deny such request.<\/p><p class=\"section\">B. Any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, shall contain specific provisions that:<\/p><p class=\"section\">1. Require the carrier to, in a method of its choosing, accept telephonic, facsimile, or electronic submission of prior authorization requests that are delivered from e-prescribing systems, electronic health record systems, and health information exchange platforms that utilize the National Council for Prescription Drug Programs' SCRIPT standards;<\/p><p class=\"section\">2. Require that the carrier communicate to the prescriber or his designee within 24 hours, including weekend hours, of submission of an urgent prior authorization request to the carrier, if submitted telephonically or in an alternate method directed by the carrier, that the request is approved, denied, or requires supplementation;<\/p><p class=\"section\">3. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a fully completed prior authorization request, that the request is approved, denied, or requires supplementation;<\/p><p class=\"section\">4. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a properly completed supplementation from the prescriber or his designee, that the request is approved or denied;<\/p><p class=\"section\">5. Require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not<em class=\"new\">, for the duration of the authorization, which shall be no less than six months for initial authorizations and 12 months for continued authorizations,<\/ins> revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety<em class=\"new\"> or efficacy<\/ins> issue that would affect the authorization alone or in combination with other authorizations; (iii)<em class=\"new\"> additional safety and efficacy<\/ins> <em class=\"new\">monitoring is clinically appropriate or<\/ins> <em class=\"new\">recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer; (iv)<\/ins> a combination of drugs prescribed would cause a drug interaction; or<s> (iv)<\/s><em class=\"new\"> (v)<\/ins> a generic or biosimilar is added to the prescription drug formulary. Nothing in this section shall require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered;<\/p><p class=\"section\">6. Require that if the prior authorization request is denied, the carrier shall communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within the timeframes established by subdivision 3 or 4, as applicable, the reasons for the denial;<\/p><p class=\"section\">7. Require that prior authorization approved by another carrier be honored, upon the carrier's receipt from the prescriber or his designee of a record demonstrating the previous carrier's prior authorization approval or any written or electronic evidence of the previous carrier's coverage of such drug, at least for the initial 90 days of a member's prescription drug benefit coverage under a new health plan, subject to the provisions of the new carrier's evidence of coverage and any exception listed in subdivision 5;<\/p><p class=\"section\">8. Require that a tracking system be used by the carrier for all prior authorization requests and that the identification information be provided electronically, telephonically, or by facsimile to the prescriber or his designee, upon the carrier's response to the prior authorization request;<\/p><p class=\"section\">9. Require that the carrier's prescription drug formularies, all drug benefits subject to prior authorization by the carrier, all of the carrier's prior authorization procedures, and all prior authorization request forms accepted by the carrier be made available through one central location on the carrier's website and that such information be updated by the carrier within seven days of approved changes;<\/p><p class=\"section\">10. Require a carrier to honor a prior authorization issued by the carrier for a drug, other than an opioid, regardless of changes in dosages of such drug, provided such drug is prescribed consistent with U.S. Food and Drug Administration-labeled dosages;<\/p><p class=\"section\">11. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the covered person changes plans with the same carrier and the drug is a covered benefit with the current health plan;<\/p><p class=\"section\">12. Require a carrier, when requiring a prescriber to provide supplemental information that is in the covered individual's health record or electronic health record, to identify the specific information required;<\/p><p class=\"section\">13. Require that no prior authorization be required for at least one drug prescribed for substance abuse medication-assisted treatment, provided that (i) the drug is a covered benefit, (ii) the prescription does not exceed the FDA-labeled dosages, and (iii) the drug is prescribed consistent with the regulations of the Board of Medicine;<\/p><p class=\"section\">14. Require that when any carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization shall be required by the carrier, provided that (i) the drug is a covered benefit; (ii) the prescription does not exceed the FDA-labeled dosages; (iii) the prescription has been continuously issued for no fewer than three months; and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. Nothing in this subdivision shall prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription for the drug is issued;<\/p><p class=\"section\">15. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued, provided that the drug and prescription are consistent with the applicable provisions of subdivision 14;<\/p><p class=\"section\">16. Require a carrier, beginning July 1, 2025, notwithstanding the provisions of subdivision 1 or any other provision of this section, to establish and maintain an online process that (i) links directly to all e-prescribing systems and electronic health record systems that utilize the National Council for Prescription Drug Programs SCRIPT standard and the National Council for Prescription Drug Programs Real Time Benefit Standard; (ii) can accept electronic prior authorization requests from a provider; (iii) can approve electronic prior authorization requests (a) for which no additional information is needed by the carrier to process the prior authorization request, (b) for which no clinical review is required, and (c) that meet the carrier's criteria for approval; (iv) links directly to real-time patient out-of-pocket costs for the prescription drug, considering copayment and deductible; and (v) otherwise meets the requirements of this section. No carrier shall (a) impose a fee or charge on any person for accessing the online process as required by this subdivision or (b) access, absent provider consent, provider data via the online process other than for the enrollee. No later than July 1, 2024, a carrier shall provide contact information of any third-party vendor or other entity the carrier will use to meet the requirements of this subdivision or the requirements of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:7\/'>38.2-3407.15:7<\/a> to any provider that requests such information. A carrier that posts such contact information on its website shall be considered to have met this requirement; and<\/p><p class=\"section\">17. Require a participating health care provider, beginning July 1, 2025, to ensure that any e-prescribing system or electronic health record system owned by or contracted for the provider to maintain an enrollee's health record has the ability to access, at the point of prescribing, the electronic prior authorization process established by a carrier as required by subdivision 16 and the real-time patient-specific benefit information, including out-of-pocket costs and more affordable medication alternatives made available by a carrier pursuant to \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:7\/'>38.2-3407.15:7<\/a>. A provider may request a waiver of compliance under this subdivision for undue hardship for a period specified by the appropriate regulatory authority with the Health and Human Resources Secretariat.<\/p><p class=\"section\">C. The Commission shall have no jurisdiction to adjudicate individual controversies arising out of this section.<\/p><p class=\"section\">D. This section shall apply with respect to any contract between a carrier and a participating health care provider or its contracting agent that is entered into, amended, extended, or renewed on or after January 1, 2016.<\/p><p class=\"section\">E. Notwithstanding any law to the contrary, the provisions of this section shall not apply to:<\/p><p class=\"section\">1. Coverages issued pursuant to Title XVIII of the Social Security Act, 42 U.S.C. \u00a7 1395 et seq. (Medicare), Title XIX of the Social Security Act, 42 U.S.C. \u00a7 1396 et seq. (Medicaid), Title XXI of the Social Security Act, 42 U.S.C. \u00a7 1397aa et seq. (CHIP), 5 U.S.C. \u00a7 8901 et seq. (federal employees), or 10 U.S.C. \u00a7 1071 et seq. (TRICARE);<\/p><p class=\"section\">2. Accident only, credit or disability insurance, long-term care insurance, TRICARE supplement, Medicare supplement, or workers' compensation coverages;<\/p><p class=\"section\">3. Any dental services plan or optometric services plan as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-4501\/'>38.2-4501<\/a>; or<\/p><p class=\"section\">4. Any health maintenance organization that (i) contracts with one multispecialty group of physicians who are employed by and are shareholders of the multispecialty group, which multispecialty group of physicians may also contract with health care providers in the community; (ii) provides and arranges for the provision of physician services by such multispecialty group physicians or by such contracted health care providers in the community; and (iii) receives and processes at least 85 percent of prescription drug prior authorization requests in a manner that is interoperable with e-prescribing systems, electronic health records, and health information exchange platforms.<\/p><p class=\"enactcls\">2. That the provisions of this act shall apply to contracts entered into, amended, or renewed on or after January 1, 2027.<\/p>",
    "catch_line": "Health insurance; required provisions regarding prior authorization for prescription drugs.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 2020,
    "patron_party": "D",
    "patron_place": "Manassas",
    "summary_hash": "de64a49ce3723652c0147feecc4f3be3",
    "patron_prefix": "Del.",
    "patron_suffix": "(D-Manassas)",
    "status_detail": "signed by governor",
    "_rsun_versions": [
        {
            "id": "7c46cc6ae3310f4182bb434881913625f1324fbaf81346ca15097562c60ee43a",
            "code": "CHAP0213",
            "bill_id": 84573,
            "source_url": null,
            "source_date": "2026-04-06",
            "source_hash": "f82558ce3583bc0d75d56ee5dab6395315fa3c9a4d19c4ea2fd82bcb4ce7343b",
            "source_html": "<p class=\"ldtitle\">An Act to amend and reenact \u00a7&nbsp;<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:2\/'>38.2-3407.15:2<\/a>, as it shall become effective, of the Code of Virginia, relating to health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.<\/p><p class=\"enactstm\">Be it enacted by the General Assembly of Virginia:<\/p><p class=\"enactcls\">1. That \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:2\/'>38.2-3407.15:2<\/a>, as it shall become effective, of the Code of Virginia is amended and reenacted as follows:<\/p><p class=\"catchln\">\u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:2\/'>38.2-3407.15:2<\/a>. (Effective January 1, 2027) Carrier contracts; required provisions regarding prior authorization for drug benefits.<\/p><p class=\"section\">A. As used in this section, unless the context requires a different meaning:<\/p><p class=\"section\">\"Carrier\" has the same meaning as provided in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">\"Prior authorization\" means the approval process used by a carrier before certain drug benefits may be provided.<\/p><p class=\"section\">\"Provider contract\" has the same meaning as provided in subsection A of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15\/'>38.2-3407.15<\/a>.<\/p><p class=\"section\">\"Supplementation\" means a request communicated by the carrier to the prescriber or his designee for additional information, limited to items specifically requested on the applicable prior authorization request, necessary to approve or deny such request.<\/p><p class=\"section\">B. Any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, shall contain specific provisions that:<\/p><p class=\"section\">1. Require the carrier to, in a method of its choosing, accept telephonic, facsimile, or electronic submission of prior authorization requests that are delivered from e-prescribing systems, electronic health record systems, and health information exchange platforms that utilize the National Council for Prescription Drug Programs' SCRIPT standards;<\/p><p class=\"section\">2. Require that the carrier communicate to the prescriber or his designee within 24 hours, including weekend hours, of submission of an urgent prior authorization request to the carrier, if submitted telephonically or in an alternate method directed by the carrier, that the request is approved, denied, or requires supplementation;<\/p><p class=\"section\">3. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a fully completed prior authorization request, that the request is approved, denied, or requires supplementation;<\/p><p class=\"section\">4. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a properly completed supplementation from the prescriber or his designee, that the request is approved or denied;<\/p><p class=\"section\">5. Require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not<em class=\"new\">, for the duration of the authorization, which shall be no less than six months for initial authorizations and 12 months for continued authorizations,<\/ins> revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety<em class=\"new\"> or efficacy<\/ins> issue that would affect the authorization alone or in combination with other authorizations; (iii)<em class=\"new\"> additional safety and efficacy<\/ins> <em class=\"new\">monitoring is clinically appropriate or<\/ins> <em class=\"new\">recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer; (iv)<\/ins> a combination of drugs prescribed would cause a drug interaction; or<s> (iv)<\/s><em class=\"new\"> (v)<\/ins> a generic or biosimilar is added to the prescription drug formulary. Nothing in this section shall require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered;<\/p><p class=\"section\">6. Require that if the prior authorization request is denied, the carrier shall communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within the timeframes established by subdivision 3 or 4, as applicable, the reasons for the denial;<\/p><p class=\"section\">7. Require that prior authorization approved by another carrier be honored, upon the carrier's receipt from the prescriber or his designee of a record demonstrating the previous carrier's prior authorization approval or any written or electronic evidence of the previous carrier's coverage of such drug, at least for the initial 90 days of a member's prescription drug benefit coverage under a new health plan, subject to the provisions of the new carrier's evidence of coverage and any exception listed in subdivision 5;<\/p><p class=\"section\">8. Require that a tracking system be used by the carrier for all prior authorization requests and that the identification information be provided electronically, telephonically, or by facsimile to the prescriber or his designee, upon the carrier's response to the prior authorization request;<\/p><p class=\"section\">9. Require that the carrier's prescription drug formularies, all drug benefits subject to prior authorization by the carrier, all of the carrier's prior authorization procedures, and all prior authorization request forms accepted by the carrier be made available through one central location on the carrier's website and that such information be updated by the carrier within seven days of approved changes;<\/p><p class=\"section\">10. Require a carrier to honor a prior authorization issued by the carrier for a drug, other than an opioid, regardless of changes in dosages of such drug, provided such drug is prescribed consistent with U.S. Food and Drug Administration-labeled dosages;<\/p><p class=\"section\">11. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the covered person changes plans with the same carrier and the drug is a covered benefit with the current health plan;<\/p><p class=\"section\">12. Require a carrier, when requiring a prescriber to provide supplemental information that is in the covered individual's health record or electronic health record, to identify the specific information required;<\/p><p class=\"section\">13. Require that no prior authorization be required for at least one drug prescribed for substance abuse medication-assisted treatment, provided that (i) the drug is a covered benefit, (ii) the prescription does not exceed the FDA-labeled dosages, and (iii) the drug is prescribed consistent with the regulations of the Board of Medicine;<\/p><p class=\"section\">14. Require that when any carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization shall be required by the carrier, provided that (i) the drug is a covered benefit; (ii) the prescription does not exceed the FDA-labeled dosages; (iii) the prescription has been continuously issued for no fewer than three months; and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. Nothing in this subdivision shall prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription for the drug is issued;<\/p><p class=\"section\">15. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued, provided that the drug and prescription are consistent with the applicable provisions of subdivision 14;<\/p><p class=\"section\">16. Require a carrier, beginning July 1, 2025, notwithstanding the provisions of subdivision 1 or any other provision of this section, to establish and maintain an online process that (i) links directly to all e-prescribing systems and electronic health record systems that utilize the National Council for Prescription Drug Programs SCRIPT standard and the National Council for Prescription Drug Programs Real Time Benefit Standard; (ii) can accept electronic prior authorization requests from a provider; (iii) can approve electronic prior authorization requests (a) for which no additional information is needed by the carrier to process the prior authorization request, (b) for which no clinical review is required, and (c) that meet the carrier's criteria for approval; (iv) links directly to real-time patient out-of-pocket costs for the prescription drug, considering copayment and deductible; and (v) otherwise meets the requirements of this section. No carrier shall (a) impose a fee or charge on any person for accessing the online process as required by this subdivision or (b) access, absent provider consent, provider data via the online process other than for the enrollee. No later than July 1, 2024, a carrier shall provide contact information of any third-party vendor or other entity the carrier will use to meet the requirements of this subdivision or the requirements of \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:7\/'>38.2-3407.15:7<\/a> to any provider that requests such information. A carrier that posts such contact information on its website shall be considered to have met this requirement; and<\/p><p class=\"section\">17. Require a participating health care provider, beginning July 1, 2025, to ensure that any e-prescribing system or electronic health record system owned by or contracted for the provider to maintain an enrollee's health record has the ability to access, at the point of prescribing, the electronic prior authorization process established by a carrier as required by subdivision 16 and the real-time patient-specific benefit information, including out-of-pocket costs and more affordable medication alternatives made available by a carrier pursuant to \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-3407.15:7\/'>38.2-3407.15:7<\/a>. A provider may request a waiver of compliance under this subdivision for undue hardship for a period specified by the appropriate regulatory authority with the Health and Human Resources Secretariat.<\/p><p class=\"section\">C. The Commission shall have no jurisdiction to adjudicate individual controversies arising out of this section.<\/p><p class=\"section\">D. This section shall apply with respect to any contract between a carrier and a participating health care provider or its contracting agent that is entered into, amended, extended, or renewed on or after January 1, 2016.<\/p><p class=\"section\">E. Notwithstanding any law to the contrary, the provisions of this section shall not apply to:<\/p><p class=\"section\">1. Coverages issued pursuant to Title XVIII of the Social Security Act, 42 U.S.C. \u00a7 1395 et seq. (Medicare), Title XIX of the Social Security Act, 42 U.S.C. \u00a7 1396 et seq. (Medicaid), Title XXI of the Social Security Act, 42 U.S.C. \u00a7 1397aa et seq. (CHIP), 5 U.S.C. \u00a7 8901 et seq. (federal employees), or 10 U.S.C. \u00a7 1071 et seq. (TRICARE);<\/p><p class=\"section\">2. Accident only, credit or disability insurance, long-term care insurance, TRICARE supplement, Medicare supplement, or workers' compensation coverages;<\/p><p class=\"section\">3. Any dental services plan or optometric services plan as defined in \u00a7\u00a0<a href='https:\/\/law.lis.virginia.gov\/vacode\/38.2-4501\/'>38.2-4501<\/a>; or<\/p><p class=\"section\">4. Any health maintenance organization that (i) contracts with one multispecialty group of physicians who are employed by and are shareholders of the multispecialty group, which multispecialty group of physicians may also contract with health care providers in the community; (ii) provides and arranges for the provision of physician services by such multispecialty group physicians or by such contracted health care providers in the community; and (iii) receives and processes at least 85 percent of prescription drug prior authorization requests in a manner that is interoperable with e-prescribing systems, electronic health records, and health information exchange platforms.<\/p><p class=\"enactcls\">2. That the provisions of this act shall apply to contracts entered into, amended, or renewed on or after January 1, 2027.<\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-04-06",
                    "number": "CHAP0213"
                }
            }
        }
    ],
    "copatron_count": 1,
    "patron_address": [
        "9108 Church Street",
        "#102",
        "Manassas",
        "VA 20108"
    ],
    "patron_chamber": "house",
    "patron_started": 2022,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "04\/06\/2026",
            "status": "Acts of Assembly Chapter text (CHAP0213)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "04\/06\/2026",
            "status": "Approved by Governor-Chapter 213 (effective 7\/1\/2026)",
            "date_raw": "2026-04-06",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "signed by governor"
        },
        {
            "date": "03\/14\/2026",
            "status": "Governor's Action Deadline 11:59 p.m., April 13, 2026",
            "date_raw": "2026-03-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/14\/2026",
            "status": "Enrolled Bill communicated to Governor on March 14, 2026",
            "date_raw": "2026-03-14",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Signed by President",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed"
        },
        {
            "date": "03\/12\/2026",
            "status": "Signed by Speaker",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB736)",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Bill text as passed House and Senate (HB736ER)",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/12\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-12",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Bill text as passed House and Senate (HB736ER)",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/09\/2026",
            "status": "Enrolled",
            "date_raw": "2026-03-09",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/05\/2026",
            "status": "Passed Senate  Block Vote (39-Y 0-N 0-A)",
            "date_raw": "2026-03-05",
            "vote_count": null,
            "lis_vote_id": "300761",
            "translation": "passed senate"
        },
        {
            "date": "03\/05\/2026",
            "status": "Read third time",
            "date_raw": "2026-03-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Passed by for the day",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Passed by for the day  Block Vote (Voice Vote)",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": "300515",
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Constitutional reading dispensed  Block Vote (on 2nd reading) (39-Y 0-N 0-A)",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": "300514",
            "translation": null
        },
        {
            "date": "03\/04\/2026",
            "status": "Rules suspended",
            "date_raw": "2026-03-04",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "03\/02\/2026",
            "status": "Reported from Commerce and Labor (13-Y 0-N)",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": "299985",
            "translation": "passed committee"
        },
        {
            "date": "03\/02\/2026",
            "status": "Reported from Commerce and Labor",
            "date_raw": "2026-03-02",
            "vote_count": null,
            "lis_vote_id": "299985",
            "translation": "passed committee"
        },
        {
            "date": "02\/18\/2026",
            "status": "Referred to Committee on Commerce and Labor",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "02\/18\/2026",
            "status": "Constitutional reading dispensed (on 1st reading)",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/17\/2026",
            "status": "Read third time and passed House  Block Vote (97-Y 0-N 0-A)",
            "date_raw": "2026-02-17",
            "vote_count": null,
            "lis_vote_id": "297750",
            "translation": "passed house"
        },
        {
            "date": "02\/17\/2026",
            "status": "Fiscal Impact Statement from Department of Planning and Budget (HB736)",
            "date_raw": "2026-02-17",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Engrossed by House as amended",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "committee amendments agreed to",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/16\/2026",
            "status": "Read second time",
            "date_raw": "2026-02-16",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/15\/2026",
            "status": "Read first time",
            "date_raw": "2026-02-15",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "02\/13\/2026",
            "status": "Reported from Appropriations (22-Y 0-N)",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297439",
            "translation": "passed committee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Reported from Appropriations",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297439",
            "translation": "passed committee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Subcommittee recommends reporting (7-Y 0-N)",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297368",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/13\/2026",
            "status": "Subcommittee recommends reporting",
            "date_raw": "2026-02-13",
            "vote_count": null,
            "lis_vote_id": "297368",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Labor and Commerce with amendment(s) and referred to Appropriations (22-Y 0-N)",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": "294896",
            "translation": "passed committee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Assigned HAPP sub: Compensation  and Retirement",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "02\/05\/2026",
            "status": "Reported from Labor and Commerce with amendment(s) and referred to Appropriations",
            "date_raw": "2026-02-05",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed committee"
        },
        {
            "date": "02\/03\/2026",
            "status": "Subcommittee recommends reporting with amendment(s) and referring to Appropriations (9-Y 0-N)",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": "294279",
            "translation": "passed subcommittee"
        },
        {
            "date": "02\/03\/2026",
            "status": "Subcommittee recommends reporting with amendment(s) and referring to Appropriations",
            "date_raw": "2026-02-03",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "passed subcommittee"
        },
        {
            "date": "01\/20\/2026",
            "status": "Assigned HCL sub: Subcommittee #1",
            "date_raw": "2026-01-20",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Referred to Committee on Labor and Commerce",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26105188D",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 485,
    "date_introduced": "2026-01-13",
    "patron_district": 20,
    "patron_shortname": "memaldonado",
    "committee_chamber": "house",
    "status_detail_date": "04\/06\/2026",
    "committee_shortname": "appropriations",
    "patron_name_formatted": "Del. Michelle Maldonado (D-Manassas)"
}